Hereditary Cancer in Clinical Practice Q3 Unclaimed
BioMed Central Ltd.
United Kingdom
Hereditary Cancer in Clinical Practice is a journal indexed in SJR in Oncology and Genetics (clinical) with an H index of 29. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2290 €. The scope of the journal is focused on cancer genetics. It has an SJR impact factor of 0,526 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,526.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Genetics (clinical) (Q3)
Oncology (Q3)
Price
2290 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,526
SJR Impact factor29
H Index38
Total Docs (Last Year)100
Total Docs (3 years)1722
Total Refs200
Total Cites (3 years)98
Citable Docs (3 years)1.51
Cites/Doc (2 years)45.32
Ref/DocOther journals with similar parameters
European Journal of Cancer Care Q3
Cancer Treatment and Research Communications Q3
ecancermedicalscience Q3
Oncology Letters Q3
Current Problems in Cancer Q3
Compare this journals
Aims and Scope
Cancer genetics
Comments